Testing IgG antibodies against the RBD of SARS-CoV-2 is sufficient and necessary for COVID-19 diagnosis.
The COVID-19 pandemic and the fast global spread of the disease resulted in unprecedented decline in world trade and travel. A critical priority is, therefore, to quickly develop serological diagnostic capacity and identify individuals with past exposure to SARS-CoV-2. In this study serum samples ob...
Main Authors: | Victoria Indenbaum, Ravit Koren, Shiri Katz-Likvornik, Mayan Yitzchaki, Osnat Halpern, Gili Regev-Yochay, Carmit Cohen, Asaf Biber, Tali Feferman, Noy Cohen Saban, Roni Dhan, Tal Levin, Yael Gozlan, Merav Weil, Orna Mor, Michal Mandelboim, Danit Sofer, Ella Mendelson, Yaniv Lustig |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0241164 |
Similar Items
-
Humoral Immunity of Unvaccinated COVID-19 Recovered vs. Naïve BNT162b2 Vaccinated Individuals: A Prospective Longitudinal Study
by: Gili Joseph, et al.
Published: (2023-06-01) -
Estimated Infection and Vaccine Induced SARS-CoV-2 Seroprevalence in Israel among Adults, January 2020–July 2021
by: Ravit Bassal, et al.
Published: (2022-10-01) -
Presence of Antibodies against Sindbis Virus in the Israeli Population: A Nationwide Cross-Sectional Study
by: Ravit Koren, et al.
Published: (2019-06-01) -
Surveillance and Diagnosis of West Nile Virus in the Face of Flavivirus Cross-Reactivity
by: Yaniv Lustig, et al.
Published: (2018-10-01) -
Reduced Neutralization Efficacy against Omicron Variant after Third Boost of BNT162b2 Vaccine among Liver Transplant Recipients
by: Yana Davidov, et al.
Published: (2023-01-01)